We are live on
!
Find out more
MIM
MetLife Investment Management Portfolio holdings
AUM
$19.6B
1-Year Est. Return
32.64%
This Fund
S&P 500
This Quarter
Est. Return
-2.49%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$12.8B
AUM Growth
-$896M
(-6.5%)
Cap. Flow
-$396M
Cap. Flow
% of AUM
-3.08%
Top 10 Holdings %
Top 10 Hldgs %
24.99%
Holding
3,035
New
97
Increased
329
Reduced
999
Closed
146
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$37.9M |
| 2 |
Blackstone
BX
|
+$16.9M |
| 3 |
Airbnb
ABNB
|
+$13.4M |
| 4 |
Kenvue
KVUE
|
+$10.4M |
| 5 |
CIVI
Civitas Resources
CIVI
|
+$7.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Bond ETF
BSV
|
+$125M |
| 2 |
Accenture
ACN
|
+$57.6M |
| 3 |
Medtronic
MDT
|
+$28M |
| 4 |
Apple
AAPL
|
+$21.2M |
| 5 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$19.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.12% |
| 2 | Healthcare | 12.03% |
| 3 | Financials | 11.49% |
| 4 | Consumer Discretionary | 10.97% |
| 5 | Industrials | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2826
Adicet Bio
ACET
$77.3M
| – | – |
-1,000
| Closed | -$38.9K |
|
|
2827
Accenture
ACN
$110B
| – | – |
-186,637
| Closed | -$57.6M |
|
2828
Adient
ADNT
$1.44B
| – | – |
-104,897
| Closed | -$4.02M |
|
2829
AerCap
AER
$23.6B
| – | – |
-9,000
| Closed | -$572K |
|
2830
Assured Guaranty
AGO
$3.29B
| – | – |
-1,125
| Closed | -$62.8K |
|
|
AKYA
2831
DELISTED
Akoya BioSciences
AKYA
| – | – |
-9,886
| Closed | -$73.1K |
|
2832
Alcon
ALC
$35.6B
| – | – |
-30,966
| Closed | -$2.57M |
|
2833
ALX Oncology
ALXO
$278M
| – | – |
-11,556
| Closed | -$86.8K |
|
2834
Ardagh Metal Packaging
AMBP
$3.02B
| – | – |
-8,391
| Closed | -$31.6K |
|
2835
Annexon
ANNX
$873M
| – | – |
-24,368
| Closed | -$85.8K |
|
2836
Aon
AON
$74.7B
| – | – |
-51,801
| Closed | -$17.9M |
|
2837
Alpha and Omega Semiconductor
AOSL
$1.09B
| – | – |
-12,204
| Closed | -$400K |
|
2838
Ardmore Shipping
ASC
$681M
| – | – |
-21,445
| Closed | -$265K |
|
2839
BioAtla
BCAB
$5.61M
| – | – |
-500
| Closed | -$74.9K |
|
2840
BioXcel Therapeutics
BTAI
$32.7M
| – | – |
-616
| Closed | -$65.6K |
|
2841
Cipher Digital
CIFR
$7.42B
| – | – |
-24,087
| Closed | -$68.9K |
|
2842
Clarivate
CLVT
$1.19B
| – | – |
-9,320
| Closed | -$88.8K |
|
|
CMBM
2843
DELISTED
Cambium Networks
CMBM
| – | – |
-6,280
| Closed | -$95.6K |
|
2844
Caledonia Mining Corp
CMCL
$441M
| – | – |
-8,720
| Closed | -$101K |
|
2845
Costamare
CMRE
$1.71B
| – | – |
-28,345
| Closed | -$274K |
|
2846
Citius Pharmaceuticals
CTXR
$21M
| – | – |
-2,790
| Closed | -$83.7K |
|
2847
Cue Biopharma
CUE
$128M
| – | – |
-617
| Closed | -$67.6K |
|
|
CYBR
2848
DELISTED
CyberArk
CYBR
| – | – |
-2,700
| Closed | -$422K |
|
2849
DHT Holdings
DHT
$3.01B
| – | – |
-72,552
| Closed | -$619K |
|
2850
Dole
DOLE
$1.23B
| – | – |
-38,168
| Closed | -$516K |
|
Similar funds
SPIA
BG
PCM
CS
HHII
LF
EIM
MetLife Investment Management's Q3 2023 Portfolio in Review
As of Q3 2023, MetLife Investment Management held 3,035 positions worth $12.8B, down 6.5% from $13.7B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
MetLife Investment Management withdrew a net $396M in Q3 2023, closing 146 positions and reducing 999 holdings. Its most notable exit was Accenture, an estimated $57.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
Against the trend, MetLife Investment Management opened a new position in Kenvue worth $9.06M.
- MetLife Investment Management's largest Q3 2023 buy was Kenvue: 451,001 shares worth $9.06M.
- MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2023, an estimated $37.9M increase.
- MetLife Investment Management's biggest Q3 2023 reduction was Vanguard Short-Term Bond ETF, cutting an estimated $125M.
- MetLife Investment Management fully exited Accenture in Q3 2023, selling an estimated $57.6M.
- MetLife Investment Management's ten largest holdings make up 25% of its $12.8B portfolio in Q3 2023.
- MetLife Investment Management opened 97 new positions and closed 146 in Q3 2023.
- MetLife Investment Management's portfolio value fell 6.5% quarter-over-quarter to $12.8B.
Based on MetLife Investment Management's 13F filing for Q3 2023, filed 14 Nov 2023.